MetLife Investment Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $138M | Sell |
563,045
-14,477
| -3% | -$3.37M | 0.7% | 17 |
|
|
2025
Q4 | $120M | Sell |
577,522
-20,001
| -3% | -$3.96M | 0.58% | 18 |
|
|
2025
Q3 | $111M | Sell |
597,523
-15,563
| -3% | -$2.67M | 0.53% | 24 |
|
|
2025
Q2 | $93.6M | Sell |
613,086
-12,348
| -2% | -$1.9M | 0.55% | 23 |
|
|
2025
Q1 | $104M | Sell |
625,434
-11,915
| -2% | -$1.86M | 0.56% | 23 |
|
|
2024
Q4 | $92.2M | Buy |
637,349
+11,299
| +2% | +$1.75M | 0.5% | 25 |
|
|
2024
Q3 | $101M | Sell |
626,050
-16,000
| -2% | -$2.55M | 0.58% | 21 |
|
|
2024
Q2 | $93.8M | Buy |
642,050
+78,326
| +14% | +$11.6M | 0.56% | 23 |
|
|
2024
Q1 | $89.2M | Sell |
563,724
-20,728
| -4% | -$3.3M | 0.6% | 22 |
|
|
2023
Q4 | $91.6M | Sell |
584,452
-11,217
| -2% | -$1.72M | 0.66% | 19 |
|
|
2023
Q3 | $92.8M | Sell |
595,669
-64,001
| -10% | -$10.6M | 0.72% | 19 |
|
|
2023
Q2 | $109M | Sell |
659,670
-15,440
| -2% | -$2.49M | 0.8% | 15 |
|
|
2023
Q1 | $105M | Sell |
675,110
-8,085
| -1% | -$1.31M | 0.75% | 16 |
|
|
2022
Q4 | $121M | Sell |
683,195
-14,771
| -2% | -$2.55M | 0.91% | 11 |
|
|
2022
Q3 | $114M | Sell |
697,966
-10,962
| -2% | -$1.85M | 0.95% | 12 |
|
|
2022
Q2 | $126M | Sell |
708,928
-7,458
| -1% | -$1.33M | 0.98% | 12 |
|
|
2022
Q1 | $127M | Buy |
716,386
+134,735
| +23% | +$22.9M | 0.82% | 13 |
|
|
2021
Q4 | $99.5M | Sell |
581,651
-12,924
| -2% | -$2.12M | 0.82% | 14 |
|
|
2021
Q3 | $96M | Sell |
594,575
-15,966
| -3% | -$2.72M | 0.86% | 13 |
|
|
2021
Q2 | $101M | Sell |
610,541
-15,873
| -3% | -$2.63M | 0.88% | 12 |
|
|
2021
Q1 | $103M | Sell |
626,414
-12,914
| -2% | -$2.09M | 0.94% | 11 |
|
|
2020
Q4 | $101M | Sell |
639,328
-28,209
| -4% | -$4.16M | 0.95% | 11 |
|
|
2020
Q3 | $99.4M | Sell |
667,537
-21,508
| -3% | -$3.18M | 1.09% | 8 |
|
|
2020
Q2 | $96.9M | Buy |
689,045
+10,646
| +2% | +$1.55M | 1.1% | 7 |
|
|
2020
Q1 | $89M | Sell |
678,399
-20,756
| -3% | -$2.94M | 1.21% | 9 |
|
|
2019
Q4 | $102M | Sell |
699,155
-19,059
| -3% | -$2.59M | 1.06% | 9 |
|
|
2019
Q3 | $92.9M | Sell |
718,214
-13,623
| -2% | -$1.79M | 1.02% | 9 |
|
|
2019
Q2 | $102M | Sell |
731,837
-25,224
| -3% | -$3.49M | 1.09% | 7 |
|
|
2019
Q1 | $106M | Sell |
757,061
-9,941
| -1% | -$1.33M | 1.15% | 6 |
|
|
2018
Q4 | $99M | Sell |
767,002
-13,432
| -2% | -$1.87M | 1.2% | 6 |
|
|
2018
Q3 | $108M | Sell |
780,434
-9,130
| -1% | -$1.21M | 1.1% | 7 |
|
|
2018
Q2 | $95.8M | Sell |
789,564
-17,827
| -2% | -$2.22M | 1.13% | 9 |
|
|
2018
Q1 | $103M | Sell |
807,391
-23,841
| -3% | -$3.22M | 1.22% | 7 |
|
|
2017
Q4 | $116M | Buy |
+831,232
| New | +$116M | 1.31% | 6 |
|
Other funds holding JNJ
VCM
VPM
MetLife Investment Management's JNJ Position: Q1 2026 in Review
MetLife Investment Management reduced its Johnson & Johnson (JNJ) stake by 2.5% in Q1 2026, selling an estimated $3.37M and leaving 563,045 shares worth $138M. The position accounts for 0.7% of the portfolio, ranked #17.
MetLife Investment Management first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- MetLife Investment Management held 563,045 shares of Johnson & Johnson worth $138M as of Q1 2026.
- MetLife Investment Management sold 14,477 Johnson & Johnson shares in Q1 2026, an estimated $3.37M.
- Johnson & Johnson made up 0.7% of MetLife Investment Management's portfolio in Q1 2026, its #17 holding.
- MetLife Investment Management first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
- 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.